Your Location:
Home >
Browse articles >
Clinical Analysis of Jieyu Anshen Particles Combined with Paroxetine Hydrochloride Tablets in Treatment of Depression After Ischemic Stroke
Updated:2024-01-04
    • Clinical Analysis of Jieyu Anshen Particles Combined with Paroxetine Hydrochloride Tablets in Treatment of Depression After Ischemic Stroke

    • SHU Jian-zhong , TANG Jun , LI Chen-yu , XUE Hong , LIU Jian-hui
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 22, Issue 13, Pages: 177-181(2016)
    • DOI: 10.13422/j.cnki.syfjx.2016130177     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

59

Views

45

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Therapeutic Mechanisms of Active Components and Compound Formulas of Astragali Radix for Ischemic Stroke: A Review
Traditional Chinese Medicine Treating Depression Through Inhibiting NLRP3 Inflammasome Pathway: A Review
Traditional Chinese Medicine Prevention and Treatment of Ischemic Stroke by Intervening in Brain Microvascular Endothelial Cells: A Review
Huanglian Jiedutang Improves Cognitive Impairment after Schemic Stroke by Regulating Neuron via NF-κB Signaling Pathway
Heat-clearing and Toxin-removing Method Reduces Ischemic Stroke Injury by Protecting Endothelial-pericyte and Inhibiting Macrophage Migration

Related Author

SHEN Yatong
FENG Xiaodong
CHEN Mo
LI Zhen
WANG Fanhong
WANG Lei
GUO Rongjuan
YAN Luomei

Related Institution

The First Affiliated Hospital of Henan University of Chinese Medicine
School of Rehabilitation Sciences,Henan University of Chinese Medicine
Xinjiang Huachun Biological Pharmaceutical Co. Ltd.
Dongfang Hospital, Beijing University of Chinese Medicine
College of Pharmacy,Xinjiang Medical University